Short-term rental of apartments consists in making a flat or premises available for the agreed use, for a specified period of time, based on agreed fee.
Short-term rental, due to the lack of its separate and comprehensive legislation, is subject to the same regulations of the Civil Code as the generally understood rental of residential premises, and therefore it is made on the basis of a rental agreement concluded between the landlord and the tenant. The premises are put into use, in the case of a short-term lease, for a fixed period of time for the fee (rent) agreed in the contract.
The importance of short-term rental in the tourism sector
The article describes the popularity of creating business entities in the Cayman Islands from the perspective of tax optimization. Leveraging one’s own economic interests with an offshore company is an interdisciplinary and multi-jurisdictional problem, and each individual investment requires the purpose of using such a solution from the perspective of the provisions on the anti-avoidance clause (Tax Ordinance) and requires ensuring proper and favorable tax jurisdiction of the owners of the offshore company, taking into account the provisions of CIT and PIT in respect of revenues from a foreign entity.
Tax optimization based on a company established in the British dependent territories – Is it a dubious “foreign remedy” for lower taxes in Poland? – Well, it depends!
On 13 December 2022, the European Commission launched the process towards the adoption of an adequacy decision for the EU-U.S. Data Privacy Framework, which will foster safe trans-Atlantic data flows and address the concerns raised by the Court of Justice of the European Union in its Schrems II decision of July 2020.
The draft adequacy decision, which reflects the assessment by the Commission of the US legal framework and concludes that it provides comparable safeguards to those of the EU, has now been published and transmitted to the European Data Protection Board (EDPB) for its opinion. The draft decision concluded that the United States ensures an adequate level of protection for personal data transferred from the EU to US companies.
Key elements of the framework decision:
US companies will be able to join the EU-U.S. Data Privacy Framework by committing to comply with a detailed set of privacy obligations, for instance, the requirement to delete personal data when it is no longer necessary for the purpose for which it was collected, and to ensure continuity of protection when personal data is shared with third parties.
EU citizens will benefit from several redress avenues if their personal data is handled in violation of the Framework, including free of charge before independent dispute resolution mechanisms and an arbitration panel.
Undoubtedly, the need to exchange IT data has been increasing for several years. One of such areas is medicine, which has already become a relatively computerized field during the COVID 19 pandemic, e.g. obtaining a referral for vaccination in Poland consisted in issuing it in the Internet IT system, it could not be obtained in a traditional written form. This is a procedure that speeds up all medical procedures, which the European Union strives to achieve by creating and disseminating the MyHealth@EU program.
MyHealth@EU
MyHealth@EU is a program that accelerates the exchange of health informatics data and can be defined as the European Health Digital Service Infrastructure. The most important assumption is that E-prescriptions and patient cards will be available in all EU countries by the end of 2025.
It is a ready-made medical device made of living cells and biomaterials, i.e. biological elements, and printed using 3D technology. It will primarily apply to patients with type 1 diabetes who experience severe complications. This is a huge breakthrough and an original idea of Polish scientists led by Dr. Michał Wszoła. This is an opportunity for patients as effective as transplantation, and at the same time less invasive compared to pancreatic islet transplantation. As a result, it will require neither a deceased donor nor immunosuppressive treatment.
